Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides

Journal of Medicinal Chemistry

Volumn 50, Issue 5, 2007, Pages 901-914

  Borza, István ^a   Bozó, Éva ^a   Barta Szalai, Gizella ^a   Kiss, Csilla ^a   Tárkányi, Gábor ^a   Demeter, Ádám ^a   Gáti, Tamás ^a   Háda, Viktor ^a   Kolok, Sándor ^a   Gere, Anikó ^a   Fodor, László ^a   Nagy, József ^a   Galgóczy, Kornél ^a   Magdó, Ildikó ^a   Ágai, Béla ^b   Fetter, József ^b   Bertha, Ferenc ^b   Keserü, György M ^a   Horváth, Csilla ^a   Farkas, Sándor ^a   Greiner, István ^a   Domány, György ^a   more..

^a GEDEON RICHTER LTD   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

(4 BENZYLPIPERIDIN 1 YL)(6 HYDROXY 1H INDOL 2 YL)METHANONE; (4 BENZYLPIPERIDIN 1 YL)[5(6) HYDROXY 1H BENZIMIDAZOL 2 YL]METHANONE; 1 (4 BENZYLPIPERIDIN 1 YL) 3 (4 HYDROXYPHENYL)PROPENONE; BENZIMIDAZOLE 2 CARBOXAMIDE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BESONPRODIL; INDOLE 2 CARBOXAMIDE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG ACTIVITY; DRUG BINDING; DRUG DETERMINATION; DRUG POTENCY; DRUG RECEPTOR BINDING; HYPERALGESIA; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANALGESICS; ANIMALS; BENZIMIDAZOLES; CALCIUM; CELLS, CULTURED; INDOLES; INTRACELLULAR SPACE; MALE; MICE; MODELS, MOLECULAR; PAIN MEASUREMENT; PATCH-CLAMP TECHNIQUES; PIPERAZINES; PROSENCEPHALON; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 33847780214     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm060420k     Document Type: Article

References (45)

1. Ueda, H.; Rashid, M. H. Molecular Mechanisms of Neuropathic Pain. Drug News Perspect. 2003, 16, 605-613.
2. Pullar, S.; Palmer, A. M. Pharmacotherapy for Neuropathic Pain: Progress and Prospects. Drug News Perspect. 2003, 16, 622-630.
3. Chazot, P. L. The NMDA Receptor NR2B Subunit: A Valid Therapeutic Target for Multiple CNS Pathologies. Curr. Med. Chem. 2004, 11, 389-396.
4. (a) Chenard, B. L.; Menniti, F. S. Antagonists Selective for NMDA Receptors Containing the NR2B Subunit. Curr. Pharm. Des. 1999, 5, 381-404.
5. (b) Nikam, S. S.; Meltzer, L. NR2B Selective NMDA Receptor Antagonists. Curr. Pharm. Des. 2002, 8, 845-855.
6. (c) McCauley, J. A. NR2B Subtype-selective NMDA Receptor Antagonists: 2001-2004. Exp. Opin. Ther. Pat. 2005, 15, 389-407.
7. (a) Chenard, B. L.; Bordner, J.; Butler, T. W.; Chambers, L. K.; Collins, M. A.; De Costa, D. L.; Ducat, M. F.; Dumont, M. L.; Fox, C. B.; Mena, E. E.; Menniti, F. S.; Nielsen, J.; Pagnozzi, M. J.; Richter, K. E. G.; Ronau, R. T.; Shalaby, I. A.; Stemple, J. Z.; White, W. F. (1S,2S)-1-(4- Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant which Blocks N-Methyl-D-aspartate Responses. J. Med. Chem. 1995, 38, 3138-3145.
8. (b) Mott, D.; Zhang, D. S.; Washburn, M. S.; Fendley, M.; Dingledine, R. CP-101,606 Antagonizes NMDA Receptors by Interacting with the Polyamine Modulatory Site. Soc. Neurosci. Abstr. 1996, 22, 66.
9. Sang, C. N.; Weaver, J. J.; Jinga, L.; Wouden, J.; Saltarelli, M. D. The NR2B Subunit-Selective NMDA Receptor Antagonist, CP-101,-606, Reduces Spontaneous Pain Intensity in Patients with Central and Peripheral Neuropathic Pain; Program No. 814.9; 2003 Abstract Viewer/Itinerary Planner; Washington, DC: Society for Neuroscience, 2003, http://sfn.scholarone.com/itin2003/index.html.
10. Wright, J. L.; Kesten, S. R.; Upasani, R. B.; Lan, N. C. PCT Int. Appl. WO2000000197-A1. 2000. Chem. Abstr. 2000, 132, 64255.
11. Fischer, G.; Mutel, V.; Traube, G.; Malherbe, P.; Kew, J. N. C.; Mohacsi, E.; Heitz, M. P.; Kemp. J. A. Ro-25,6981, a Highly Potent and Selective Blocker of N-Methyl-D-aspartate Receptors Containing the NR2B Subunit. Characterization In Vitro. J. Pharmacol. Exp. Ther. 1997, 283, 1285-1292.
12. (a) Thompson, W.; Claremon, D. A.; Munson, P. M.; Whitter, W.; Kulagowski, J.; Huscroft, I. PCT Int. Appl. WO 200132615-A1. Example 12. Chem. Abstr. 2001, 134, 340510.
13. (b) McCauley, J. A.; Theberge, C. R.; Romano, J. J.; Billings, S. B.; Anderson, K. D.; Claremon, D. A.; Freidinger, R. M.; Bednar, R. A.; Mosser, S. D.; Gaul, S. L.; Connolly, T. M.; Condra, C. L.; Xia, M.; Cunningham, M. E.; Bednar, B.; Stump, G. L.; Lynch, J. J.; Macaulay, A.; Wafford, K. A.; Koblan, K. S.; Liverton, N. J. NR2B-Selective N-Methyl-D-aspartate Antagonists: Synthesis and Evaluation of 5-Substituted Benzimidazoles. J. Med. Chem. 2004, 47 (8), 2089-2096.
14. Tamiz, A. P.; Cai, S. X.; Zhou, Z.; Yuen, P.; Schelkun, R. M.; Whittemore, E. R.; Weber, E.; Woodward, R. M.; Keana, J. F. W. Structure-Activity Relationship of N-(Phenylalkyl)cinnamides as Novel NR2B Subtype-Selective NMDA Receptor Antagonists. J. Med. Chem. 1999, 42, 3412-3420.
15. McCauley, J. A. Amide-Containing NR2B/NMDA Receptor Antagonists, Pfizer, Inc.; WO2005080317. Exp. Opin. Ther. Pat. 2006, 16 (6), 863-870.
16. (a) Borza, I.; Kolok, S.; Gere, A.; Ágai-Csongor, É.; Ágai, B.; Tárkányi, G.; Horváth, Cs.; Barta-Szalai, G.; Bozó, E.; Kiss, Cs.; Bielik, A.; Nagy, J.; Farkas, S.; Domány, Gy. Indole-2-carboxamides as Novel NR2B Selective NMDA Receptor Antagonists. Bioorg. Med. Chem. Lett. 2003, 13, 3859-3861.
17. (b) Borza, I.; Kolok, S.; Gere, A.; Nagy, J.; Fodor, L.; Galgóczy, K.; Fetter, J.; Bertha, F.; Ágai, B.; Horváth, Cs.; Farkas, S.; Domány, Gy. Benzimidazole-2-carboxamides as Novel NR2B Selective NMDA Receptor Antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 4638-4640.
18. Nicolaou, K. C.; Ramanjulu, J. M.; Natarajan, S.; Braese, S.; Li, H.; et al. A Suzuki Coupling-Macrolactamization Approach to the AB-COD Bicyclic System of Vancomycin. Chem. Commun. 1997, 19, 1899-1900.
19. (a) Kondo, K.; Morohoshi, S.; Mitsuhashi, M.; Murakami, Y. Chem. Pharm. Bull. 1999, 47, 1227.
20. (b) Boger, D. L.; Cerbone, L. R.; Yohannes, D. Oxidative Coupling of Methyl 6-Hydroxyindole-2-carboxylate with Primary Amines: Preparation of 2-Substituted Methyl Pyrrolo[2,3-e]benzoxazole-5-carboxylates. J. Org. Chem. 1988, 53, 5163.
21. Tois, J.; Franzen, R.; Aitio, O.; Huikko, K.; Taskinen, J. Preparation of 5-Substituted 2-Carboxyindoles on Solid Support. Tetrahedron Lett. 2000, 14, 2443-2446.
22. Doyle, F. P.; Ferrier, W.; Holland, D. O.; Mehta, M. D.; Nayler, J. H. C. Potential Antituberculosis Agents of the Indole Series. J. Chem. Soc. 1956, 78, 2853-2856.
23. Davis, P.; NL 6409825. Chem. Abstr. 1965, 63, 11517d.
24. Xue, C. B.; Roderick, J.; Jackson, S.; Rafalski, M.; Rockwell, A.; Mousa, S.; Olson, R. E.; DeGrado, W. F. Design. Synthesis, and In Vitro Activities of Benzamide-Core Glycoprotein Iib/IIIa Antagonists: 2,3-Diaminopropionic Acid Derivatives as Surrogates of Aspartic Acid. Bioorg. Med. Chem. 1997, 5, 693-705.
25. Lu, T.; Soil, R. M.; Illig, C. R.; Bone, R.; Murphy, L.; Spurlino, J.; Salemme, R. R.; Tomczuk, B. E. Structure-Activity and Crystallographic Analysis of a New Class of Nonamide-Based Thrombin Inhibitor. Bioorg. Med. Chem. Lett. 2000, 10, 79-82.
26. (a) Ágai, B.; Nádor, A.; Proszenyák, Á.; Tárkányi, G.; Faigl, F. A Facile Synthesis of 3-(Substituted Benzyl)piperidines. Tetrahedron 2003, 59, 7897-7900.
27. (b) Ágai, B.; Proszenyák, Á.; Tárká nyi, G.; Vida, L.; Faigl, F. Convenient, Benign, and Scalable Synthesis of 2-and 4-Substituted Benzylpiperidines. Eur. J. Org. Chem. 2004, 3623-3632.
28. (c) Proszenyák, A.; Ágai, B.; Hegedüs, L.; Faigl, F. Hydrogenation of a 4-Benzylpiperidine Derivative over Supported Precious Metal Catalysts. Appl. Catal., A 2004, 269, 249-253.
29. (a) Kondo, K.; Morohoshi, S.; Mitsuhashi, M.; Murakami, Y. Chem. Pharm. Bull. 1999, 47, 1227.
30. (b) Boger, D. L.; Cerbone, L. R.; Yohannes, D. Oxidative Coupling of Methyl 6-Hydroxyindole-2-carboxylate with Primary Amines: Preparation of 2-SubstitutedMethyl Pyrrolo[2,3-e]benzoxazole-5-carboxylates. J. Org. Chem. 1988, 53, 5163.
31. Crowther, A. F.; Curd, F. H. S.; Davey, D. G.; Stacey, G. J. Synthetic Antimalarials. Dialkylaminoalkylaminoquinoxalines. J. Chem. Soc. 1949, 1260.
32. Nagy, J.; Horváth, Cs.; Farkas, S.; Kolok, S.; Szombathelyi, Zs. NR2B Subunit Selective NMDA Antagonists Inhibit Neurotoxic Effect of Alcohol-Withdrawal in Primary Cultures of Rat Cortical Neurones. Neurochem. Int. 2004, 44, 17-23.
33. Zhong, J.; Russell, S. L.; Pritchett, D. B.; Molinoff, P. B.; Williams, K. Expression of mRNAs Encoding Subunits of the N-Methyl-D- aspartate Receptor in Cultured Cortical Neurons. Mol. Pharmacol. 1994, 45 (5), 846-853.
34. 3H]Ro 25-6981, a Potent and Selective Antagonist of NMDA Receptors Containing NR2B Subunits. J. Neurochem. 1998, 70, 2147-2155.
35. 3H]-Ro 25-6981 in Rat Brain. Br. J. Pharmacol. 1997, 120, proc. suppl., 39P.
36. Mistry, M.; Houston, J. B. Quantitation of Extrahepatic Metabolism. Pulmonary and Intestinal Conjugation of Naphthol. Drug Metab. Dispos. 1985, 13, 740-745.
37. Kugler-Steigmeier, M. E.; Friedrich, U.; Graf, U.; Lutz, W. K.; Maier, P.; Schlatter, Ch. Genotoxicity of Aniline Derivatives in Various Short-Term Tests. Mut. Res. 1989, 211, 279-289.
38. Wermuth, C. G. In The Practice of Medicinal Chemistry; Wermuth, C. G., Ed.; Academic Press: London, San Diego, New York, Boston, Sydney, Tokyo, Toronto, 1996; p 228.
39. Kurko, D.; Dezsö, P.; Boros, A.; Kolok, S.; Fodor, L.; Nagy, J.; Szombathelyi, Zs. Inducible Expression and Pharmacological Characterization of Recombinant Rat NR1a/NR2A NMDA Receptors. Neurochem. Int. 2005, 46, 369-379.
40. Hunskaar, S.; Fasmer, O. B.; Hole, K. Formalin Test in Mice, a Useful Technique for Evaluating Mild Analgesics. J. Neurosci. Methods 1985, 14, 69-76.
41. Chaplan, S. R.; Malmberg, A. B.; Yaksh, T. L. Efficacy of Spinal NMDA Receptor Antagonism in Formalin Hyperalgesia and Nerve Injury Evoked Allodynia in the Rat. J. Pharm. Exp. Ther. 1997, 280, 829-838.
42. Klebe, G.; Abraham, U.; Mietzner, T. Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict their Biological Activity. J. Med. Chem. 1994, 37, 4130-4146.
43. Martin, Y.; Bures, M.; Danaher, V.; DeLazzer, J.; Lico, I. A Fast New Approach to Pharmacophore Mapping and its Application to Dopaminergic and Benzodiazepine Agonists. J. Comp.-Aided Mol. Des. 1993, 7, 83-102.
44. 2 ! J. Mol. Graphics Modell. 2002, 20, 269-276.
45. Sybyl 6.8; Tripos Inc.: 1699 South Hanley Rd., St. Louis, Missouri, 63144, 2001.